from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0606/-

LFCtreatmentdescriptionclass of inhibitor

-0.526

Amikacinug/mL Amikacintranslation

-0.467

Cap5-10ug/mL Capreomycintranslation

-0.243

Rox10-50 ug/mL Roxithromycintranslation

-0.248

SM2-5 ug/mL Streptomycintranslation

-0.243

Tet5-10 ug/mL Tetracyclinetranslation

-1.346

Rif0.2-5ug/mL Rifampicintranscription

-1.041

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.077

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.405

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.019

CPZ10-50 ug/mL Chlorpromazinerespiration

1.630

Clofazimine10-13 ug/mL Clofaziminerespiration

0.017

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.902

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.417

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.475

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.009

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.162

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.065

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.133

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.318

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.715

KCN5-20 ug/mL Potassium cyaniderespiration

-0.399

NaN30.2-2 mM Sodium aziderespiration

0.273

Nigericin50 uM Nigericinrespiration

-0.479

TRC10-150 ug/mL Triclosanrespiration

-0.060

TRZ10-25 ug/mL Thioridazinerespiration

0.730

Valinomycin0.5-10 uM Valinomycinrespiration

-0.301

ZnSO42 mM ZnSO4respiration

1.185

menadione6-10 ug/mL Menadionerespiration

-0.079

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.360

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.313

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.337

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.165

NRP_1Non-replicating persistence stage 1dosRassociated

-0.596

Amp0.2mg/mL AmpicillincellWall

-0.334

Cephalexin20-100 ug/mL CephalexincellWall

-0.312

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.976

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.802

EMB10-20 ug/mL EthambutolcellWall

-0.528

Eta12-40 ug/mL EthionamidecellWall

-0.479

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.557

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.281

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.245

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.452

BZA0.12 mg/mL BenzamidearomaticAmides

-0.464

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.410

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.789

H2O24 mM hydrogen peroxideDNAdamaging

2.560

Levo10 ug/mL LevofloxacinDNAdamaging

0.831

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.637

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.484

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.873

UVUV-irradiationDNAdamaging

0.566

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.237

Antimycin12.5-50 ug/mL Antimycin A?

-0.313

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.192

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.179

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.873

PA8240.2-2 ug/mL PA-824?

-0.190

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.358

Verapamil50 uM Verapamil?

-0.333

mercaptoethanol2 mM 2-Mercaptoethanol?

0.023

methoxatin10-20 ug/mL Methoxatin?